Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Watch
Expert ConversationsNews & AnalysisShows & Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
Conferences
Conference CoverageConference ListingPost Conference Perspectives
More
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

Paul A. Heidenreich, MD, MS

Advertisement

Articles by Paul A. Heidenreich, MD, MS

Patient Ratings of Veterans Affairs and Affiliated Hospitals

ByPaul A. Heidenreich, MD, MS,Aimee Zapata, MS,Lisa Shieh, MD, PhD,Nancy Oliva, PhD, RN,Anju Sahay, PhD
June 28th 2017

The mean online patient rating for Veterans Affairs hospitals was higher (3.70 ± 1.3 out of 5) than the rating for affiliated hospitals (3.19 ± 1.3; P = .003).

Mental Illness and Warfarin Use in Atrial Fibrillation

ByGraham A. Walker, MD,Paul A. Heidenreich, MD, MS,Ciaran S. Phibbs, PhD,Alan S. Go, MD,Victor Y. Chiu, BA,Susan K. Schmitt, PhD,Lakshmi Ananth, MS,Susan M. Frayne, MD, MPH
September 6th 2011

Atrial fibrillation patients with mental illness are less likely to receive warfarin anticoagulation; those who do receive warfarin have excess risk of over-anticoagulation.

Advertisement

Latest Updated Articles

  • Patient Ratings of Veterans Affairs and Affiliated Hospitals
    Patient Ratings of Veterans Affairs and Affiliated Hospitals

    June 28th 2017

  • Mental Illness and Warfarin Use in Atrial Fibrillation
    Mental Illness and Warfarin Use in Atrial Fibrillation

    September 6th 2011



Advertisement
Advertisement

Trending on AJMC

1

FDA Panel Backs 6 Peptides for Compounding

2

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

3

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

4

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

5

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text